JP2008514563A5 - - Google Patents

Download PDF

Info

Publication number
JP2008514563A5
JP2008514563A5 JP2007532823A JP2007532823A JP2008514563A5 JP 2008514563 A5 JP2008514563 A5 JP 2008514563A5 JP 2007532823 A JP2007532823 A JP 2007532823A JP 2007532823 A JP2007532823 A JP 2007532823A JP 2008514563 A5 JP2008514563 A5 JP 2008514563A5
Authority
JP
Japan
Prior art keywords
mic
test results
table below
antibacterial test
typical antibacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007532823A
Other languages
English (en)
Japanese (ja)
Other versions
JP4887297B2 (ja
JP2008514563A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/010154 external-priority patent/WO2006032466A2/en
Publication of JP2008514563A publication Critical patent/JP2008514563A/ja
Publication of JP2008514563A5 publication Critical patent/JP2008514563A5/ja
Application granted granted Critical
Publication of JP4887297B2 publication Critical patent/JP4887297B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007532823A 2004-09-24 2005-09-20 新規二環式抗生物質 Expired - Fee Related JP4887297B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EPPCT/EP2004/010762 2004-09-24
EP2004010762 2004-09-24
EPPCT/EP2005/007731 2005-07-15
EP2005007731 2005-07-15
PCT/EP2005/010154 WO2006032466A2 (en) 2004-09-24 2005-09-20 New bicyclic antibiotics

Publications (3)

Publication Number Publication Date
JP2008514563A JP2008514563A (ja) 2008-05-08
JP2008514563A5 true JP2008514563A5 (enExample) 2011-12-08
JP4887297B2 JP4887297B2 (ja) 2012-02-29

Family

ID=36090370

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007532823A Expired - Fee Related JP4887297B2 (ja) 2004-09-24 2005-09-20 新規二環式抗生物質

Country Status (5)

Country Link
JP (1) JP4887297B2 (enExample)
AR (1) AR050958A1 (enExample)
CA (1) CA2580621A1 (enExample)
TW (1) TW200615267A (enExample)
WO (1) WO2006032466A2 (enExample)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7709472B2 (en) 2005-01-25 2010-05-04 Glaxo Group Limited Antibacterial agents
WO2006125974A1 (en) * 2005-05-24 2006-11-30 Astrazeneca Ab Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
WO2007086016A1 (en) 2006-01-26 2007-08-02 Actelion Pharmaceuticals Ltd Tetrahydropyrane antibiotics
EP1987040B1 (en) 2006-02-15 2010-11-10 Actelion Pharmaceuticals Ltd. Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives
CA2643962A1 (en) * 2006-03-10 2007-09-20 Actelion Pharmaceuticals Ltd Antibiotic compounds
ATE481406T1 (de) 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
EP2044059A1 (en) * 2006-06-08 2009-04-08 Speedel Experimenta AG 2,5-disubstituted piperidines
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
TW200819457A (en) * 2006-08-30 2008-05-01 Actelion Pharmaceuticals Ltd Spiro antibiotic derivatives
CL2007003693A1 (es) * 2006-12-22 2008-06-27 Actelion Pharmaceuticals Ltd Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas.
CL2008001002A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008001003A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
JP5389013B2 (ja) 2007-04-20 2014-01-15 グラクソ グループ リミテッド 抗菌剤としての三環式含窒素化合物
JP5274553B2 (ja) * 2007-06-15 2013-08-28 アクテリオン ファーマシューティカルズ リミテッド 3−アミノ−6−(1−アミノ−エチル)−テトラヒドロピラン誘導体
EP2005995A1 (en) * 2007-06-22 2008-12-24 Glaxo Group Limited Heterocyclic compounds for the treatment of tuberculosis
JP5323088B2 (ja) 2007-12-18 2013-10-23 アクテリオン ファーマシューティカルズ リミテッド 5−アミノシクリルメチル−オキサゾリジン−2−オン誘導体
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
US8349828B2 (en) 2008-02-20 2013-01-08 Actelion Pharmaceuticals Ltd. Azatricyclic antibiotic compounds
TW200944529A (en) 2008-04-15 2009-11-01 Actelion Pharmaceuticals Ltd Tricyclic antibiotics
US8349829B2 (en) 2008-06-03 2013-01-08 Actelion Pharmaceuticals Ltd. [4-(1-amino-ethyl)-cyclohexyl]-methyl-amine and [6-(1-amino-ethyl)-tetrahydro-pyran-3-yl]-methyl-amine derivatives as antibacterials
BRPI0916571A2 (pt) 2008-08-04 2015-11-10 Actelion Pharmaceuticals Ltd composto derivado de alquilaminometiloxazolidinona tricíclo, medicamento e composição farmacêutica que o contém e uso do composto
PT2344495E (pt) 2008-10-07 2015-04-01 Actelion Pharmaceuticals Ltd Compostos antibióticos de oxazolidinona tricíclica
EP2352734A1 (en) 2008-10-17 2011-08-10 Glaxo Group Limited Tricyclic nitrogen compounds used as antibacterials
MX2011005120A (es) 2008-11-17 2011-05-30 Hoffmann La Roche Acidos naftilaceticos.
NZ593891A (en) * 2008-12-12 2013-05-31 Actelion Pharmaceuticals Ltd 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
JP5653935B2 (ja) 2009-01-15 2015-01-14 グラクソ グループ リミテッドGlaxo Group Limited 抗菌薬として有用なナフチリジン―2(1h)−オン化合物
US8716280B2 (en) 2009-01-21 2014-05-06 Basilea Pharmaceutica Ag Bicyclic antibiotics
AR076222A1 (es) 2009-04-09 2011-05-26 Actelion Pharmaceuticals Ltd Derivados 2-hidroxietil-1h-quinolin-ona y sus analogos azaisotericos con actividad antibacteriana y composiciones farmaceuticas que los contienen
EP2621902B1 (en) 2010-09-28 2017-04-12 Panacea Biotec Ltd 3-azabicyclo[3.1.0]hexane compounds useful for the treatment of cns disorders
DK2684880T3 (en) 2011-03-10 2018-05-22 Daiichi Sankyo Co Ltd DISPIROPYRROLIDINE DERIVATIVES
US20140005165A1 (en) * 2011-03-17 2014-01-02 Anilkumar G. Nair Substituted 3-azabicyclo[3.1.0]hexane derivatives useful as ccr2 antagonists
TWI565706B (zh) * 2011-06-17 2017-01-11 阿斯特捷利康公司 用於製備包括反-7-酮基-6-(磺酸氧基)-1,6-二氮雜雙環[3,2,1]辛烷-2-甲醯胺之雜環化合物及其鹽類之方法
EP2723737A1 (en) * 2011-06-27 2014-04-30 Kyorin Pharmaceutical Co., Ltd. Bridged bicyclic compounds for the treatment of bacterial infections
US8470884B2 (en) 2011-11-09 2013-06-25 Hoffmann-La Roche Inc. Alkenyl naphthylacetic acids
CN103958525A (zh) 2011-11-30 2014-07-30 埃科特莱茵药品有限公司 3,7-二取代八氢-2H-吡啶并[4,3-e][1,3]噁嗪-2-酮抗生素
EP3639824A1 (en) 2014-08-22 2020-04-22 GlaxoSmithKline Intellectual Property Development Limited Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
DK3676297T3 (da) * 2017-09-01 2023-08-14 Denali Therapeutics Inc Forbindelser, sammensætninger og fremgangsmåder
MY202326A (en) 2017-09-14 2024-04-24 Daiichi Sankyo Co Ltd Compound having cyclic structure
CN109082280B (zh) * 2018-11-05 2020-07-28 宁夏中星显示材料有限公司 一种液晶材料的制备方法
MA54959A (fr) 2019-02-13 2021-12-22 Denali Therapeutics Inc Composés, compositions et procédés

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004089942A2 (en) * 2001-10-02 2004-10-21 Acadia Pharmaceuticals Inc. Benzimidazolidinone derivatives as muscarinic agents
WO2003064421A1 (en) * 2002-01-29 2003-08-07 Glaxo Group Limited Aminopiperidine derivatives
TW200406413A (en) * 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
TW200409637A (en) * 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
BR0315221A (pt) * 2002-10-10 2005-08-23 Morphochem Ag Komb Chemie Compostos com atividade antibacteriana
DE10256405A1 (de) * 2002-12-02 2004-06-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Topoisomerase IV inhibieren
DE10316081A1 (de) * 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
US20070270417A1 (en) * 2004-07-22 2007-11-22 Glaxo Group Limited Antibacterial Agents
DE102004041163A1 (de) * 2004-08-25 2006-03-02 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität

Similar Documents

Publication Publication Date Title
JP2008514563A5 (enExample)
JP2008512492A5 (enExample)
JP2005194118A5 (enExample)
JP2006257115A5 (enExample)
JP2008542211A5 (enExample)
JP2005261231A5 (enExample)
JP2007514712A5 (enExample)
JP2008512398A5 (enExample)
JP2009506999A5 (enExample)
JP2007520206A5 (enExample)
JP2007505861A5 (enExample)
JP2005120465A5 (enExample)
JP2006063441A5 (enExample)
JP2007119645A5 (enExample)
JP2006045672A5 (enExample)
JP2007500762A5 (enExample)
JP2005095148A5 (enExample)
JP2005290409A5 (enExample)
JP2006101735A5 (enExample)
JP2008525570A5 (enExample)
JP2006523255A5 (enExample)
JP2008524415A5 (enExample)
JP2006273834A5 (enExample)
JP2007001784A5 (enExample)
JP2008525527A5 (enExample)